November 01, 2025

Get In Touch

Different Modalities Of Accupuncture Reduce Chronic Pain In Cancer Survivors: JAMA

Acupuncture Study in Cancer Survivors

Acupuncture Study in Cancer Survivors

Electroacupuncture and auricular acupuncture may help in greater reduction of chronic pain versus usual care in cancer survivors with chronic musculoskeletal pain, finds a recent study in the journal JAMA Oncology. Further, auricular acupuncture was not found to be noninferior to electroacupuncture and patients who received it experienced more adverse effects.

In the current scenario of opioid crisis, challenges arise for cancer pain management. The use of acupuncture is shown to provide clinical benefits for chronic nonmalignant pain, but its effectiveness in cancer survivors remains uncertain. Jun J. Mao, Memorial Sloan Kettering Cancer Center, New York, New York, and colleagues, therefore, aimed to determine the effectiveness of electroacupuncture or auricular acupuncture for chronic musculoskeletal pain in cancer survivors.

For the purpose, the researchers performed Personalized Electroacupuncture vs Auricular Acupuncture Comparativeness Effectiveness (PEACE) trial. The trial was a randomized clinical trial that was conducted from March 2017 to October 2019 across an urban academic cancer center and 5 suburban sites in New York and New Jersey.

The study included 360 adults with a prior cancer diagnosis but no current evidence of disease, reported musculoskeletal pain for at least 3 months, and self-reported pain intensity on the Brief Pain Inventory (BPI) ranging from 0 (no pain) to 10 (worst pain imaginable).

They were randomized in a ratio of 2:2:1 to receive electroacupuncture (n = 145), auricular acupuncture (n = 143), or usual care (n = 72). Intervention groups received 10 weekly sessions of electroacupuncture or auricular acupuncture. Ten acupuncture sessions were offered to the usual care group from weeks 12 through 24.

Key Findings of the Study

  • Among 360 cancer survivors, 340 (94.4%) completed the primary end point.
  • Compared with usual care, electroacupuncture reduced pain severity by 1.9 points and auricular acupuncture reduced by 1.6 points from baseline to week 12.
  • Noninferiority of auricular acupuncture to electroacupuncture was not demonstrated.
  • Adverse events were mild; 15 of 143 (10.5%) patients receiving auricular acupuncture and 1 of 145 (0.7%) patients receiving electroacupuncture discontinued treatments due to adverse events.

"In this randomized clinical trial among cancer survivors with chronic musculoskeletal pain, electroacupuncture and auricular acupuncture produced greater pain reduction than usual care," wrote the authors. "However, auricular acupuncture did not demonstrate noninferiority to electroacupuncture, and patients receiving it had more adverse events."

Reference

The study titled, "Effectiveness of Electroacupuncture or Auricular Acupuncture vs Usual Care for Chronic Musculoskeletal Pain Among Cancer Survivors: The PEACE Randomized Clinical Trial," is published in the journal JAMA Oncology.

DOI: https://jamanetwork.com/journals/jamaoncology/article-abstract/2777349

Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our Terms of Use, Privacy Policy, and Advertisement Policy.
For further details, please review our Full Disclaimer.

0 Comments

Post a comment

Please login to post a comment.

No comments yet. Be the first to comment!